期刊
INFLAMMATORY BOWEL DISEASES
卷 19, 期 2, 页码 254-258出版社
OXFORD UNIV PRESS INC
DOI: 10.1097/MIB.0b013e318281007c
关键词
adalimumab; rabbits; intestinal anastomosis; intestinal healing; tensile strength
资金
- Research Foundation at Odense University Hopsital
Background: Adalimumab is a TNF-alpha inhibitor, which has gained wide use in the treatment of inflammatory bowel diseases. The potential detrimental effect of TNF-alpha inhibitors on postoperative complications such as anastomotic leakage is unknown. The aim of this study was to investigate the effect of a single therapeutic dose of adalimumab on anastomotic strength inflammation and collagen formation. Methods: Twenty-eight female rabbits (1.8-2.2 kg) were allocated to subcutaneous injection with either adalimumab (1.5 mg/ kg) (n=14) or placebo (n=14). One week after medication two separate end-to-end anastomoses were performed in the jejunum. The rabbits were killed on the third postoperative day. The anastomosis were subjected to tensile strength analysis and histopathological examination. Results: No statistically significant differences were found between the two groups regarding maximum tensile strength, inflammation parameters and collagen formation in the anastomosis area. Multiple regression analysis showed no association between maximum tensile strength histological changes, time under anaesthesia, duration of surgery, weight gain, weight loss and number of sutures in either group. Conclusion: We found no statistically significant effect of a single therapeutic dose of adalimumab on anastomotic strength, histological parameters or collagen formation in rabbits. (Inflamm Bowel Dis 2013;19:254-258)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据